STAT+: Pharmalittle: FDA adds Lilly diabetes drugs to shortage list; WTO delays decision on extending Covid IP waiver
STAT
DECEMBER 19, 2022
Food and Drug Administration added Eli Lilly’s Mounjaro to its list of drugs facing shortages, highlighting the company’s struggles to meet booming demand for the newly approved diabetes injection , STAT notes.
Let's personalize your content